- Home
- ITP vs REVB Comparison
ITP vs REVB Comparison
Compare ITP & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITP
- REVB
- Stock Information
- Founded
- ITP 1996
- REVB 2020
- Country
- ITP China
- REVB United States
- Employees
- ITP N/A
- REVB N/A
- Industry
- ITP Paper
- REVB Biotechnology: Pharmaceutical Preparations
- Sector
- ITP Basic Materials
- REVB Health Care
- Exchange
- ITP Nasdaq
- REVB Nasdaq
- Market Cap
- ITP 2.6M
- REVB 2.2M
- IPO Year
- ITP N/A
- REVB N/A
- Fundamental
- Price
- ITP $0.20
- REVB $0.86
- Analyst Decision
- ITP
- REVB
- Analyst Count
- ITP 0
- REVB 0
- Target Price
- ITP N/A
- REVB N/A
- AVG Volume (30 Days)
- ITP 17.4M
- REVB 2.8M
- Earning Date
- ITP 05-09-2025
- REVB 05-08-2025
- Dividend Yield
- ITP N/A
- REVB N/A
- EPS Growth
- ITP N/A
- REVB N/A
- EPS
- ITP N/A
- REVB N/A
- Revenue
- ITP $79,871,368.00
- REVB N/A
- Revenue This Year
- ITP N/A
- REVB N/A
- Revenue Next Year
- ITP N/A
- REVB N/A
- P/E Ratio
- ITP N/A
- REVB N/A
- Revenue Growth
- ITP 8.49
- REVB N/A
- 52 Week Low
- ITP $0.15
- REVB $0.77
- 52 Week High
- ITP $1.07
- REVB $60.80
- Technical
- Relative Strength Index (RSI)
- ITP 46.95
- REVB 20.22
- Support Level
- ITP $0.16
- REVB $0.78
- Resistance Level
- ITP $0.22
- REVB $1.15
- Average True Range (ATR)
- ITP 0.02
- REVB 0.23
- MACD
- ITP 0.00
- REVB -0.15
- Stochastic Oscillator
- ITP 66.83
- REVB 3.38
About ITP IT Tech Packaging Inc.
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).